From Wikipedia, the free encyclopedia
|Chemical and physical data|
|Molar mass||145.9 kg/mol|
|(what is this?)|
Narnatumab was developed by ImClone Systems.
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab" (PDF). American Medical Association.
- "Narnatumumab". AdisInsight. Retrieved 31 January 2017.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|